This is a routine tax-withholding sale by an insider following equity vesting. The dollar amount is negligible relative to market cap. No trading action warranted; monitor for any larger insider sales or changes in beneficial ownership.
How the stock moved after the report
NEUTRAL VIEWSTOCK AT ENTRY AT T+20- T+0 · May 13 $0.0193entry
- T+1 · 6mo ago 0.00%α −0.78% · $0.0193
- T+5 · 6mo ago 0.00%α +0.14% · $0.0193
- T+20 · 5mo ago 0.00%α +0.61% · $0.0193
- T+60 · due 3mo ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Gaurav Shah, an officer and director of Rocket Pharmaceuticals, filed a Form 144 notice of intent to sell 2,728 shares of common stock, with an approximate market value of $9,836. The shares were acquired on May 11, 2026, through restricted stock vesting as compensation. This is a routine, small-dollar sale by an insider to cover tax obligations from equity vesting, with no material impact on the company's outlook.
Key Facts
- Insider Gaurav Shah (Officer and Director) filed Form 144 to sell 2,728 shares
- Estimated sale value: $9,836.08
- Shares acquired on May 11, 2026 via restricted stock vesting (compensation)
- Sale is to cover tax obligations from vested equity award distribution
- Company market cap is approximately $1 million (RCKTW)
Financial Impact
Approximately $9,836, less than 1% of the company's market cap
Risk Factors
- Insider selling pattern could emerge if additional Form 144s are filed
- Low market cap and limited liquidity may amplify any selling pressure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-003569 |
| Document: 0001959173-26-003569-index.html | 0001959173-26-003569 |
| Document: 0001959173-26-003569.txt | 0001959173-26-003569 |
Track record
4 reports on RCKTW
The track record builds as more bullish or bearish reports settle.
Filters
- May 13, 202626w ago 144 Neutral 2/10 Viewing Entry $0.0193 No price data
- May 7, 202627w ago 8-K Mixed 6/10 Entry $0.0193 to $0.001800 ▼ −90.67% −95.51% vs SPY
- May 7, 202627w ago 144 Neutral 3/10 Entry $0.0193 to $0.003200 ▼ −83.42% −87.25% vs SPY
- Apr 28, 202628w ago 8-K Bullish 8/10 Entry $0.0193 to $0.002700 ▼ −86.01% −90.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers